Global Single-Cell Multi-Omics Market (2020-2025): Focus on Product Type, Omics Type, Sample Type, Technique, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Market Report Coverage - Single-Cell Multi-Omics
Market Segmentation
1CellBio, Inc., Fluidigm Corporation, 10x Genomics, Inc., NanoString Technologies, Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Mission Bio, Dolomite Bio, Fluxion Biosciences, Berkeley Lights, Inc., RareCyte, Inc., Becton, Dickinson and Company, Takara Bio, Inc., Thermo Fisher Scientific Inc., Namocell, Inc.
Key Questions Answered in this Report:
BIS Research healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others.
The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development. The gradual increase in the prevalence of oncology and rare diseases globally has furthered the single-cell multi-omics market.
Furthermore, several contract research organizations are focusing on the development of single-cell technology-based services, which enable simultaneous analysis of genomics, proteomics, and transcriptomics, providing deeper insights on a disease progression.
Within the research report, the market is segmented on the basis of product type, sample type, omics type, technique, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of high-resolution multiplex diagnostics providing information on cellular interaction and tissue heterogeneity to understand disease biology and pathology. Due to technologically advanced solutions and intense market penetration, 10x Genomics, Inc. has been a pioneer and a significant competitor in this market.
Other key players in the market are NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation.
On the basis of region, North America holds the largest share of the single-cell multi-omics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific is anticipated to grow at the fastest CAGR of 21.53% during the forecast period 2020-2025.
The market utilizes several technologies, such as barcoding, sequencing, mass cytometry, and microscopy, for the development of instruments and assays for single-cell analysis of tissue and cells to gain an understanding of cell heterogeneity and cellular mechanism. Each solution offered by the leading players is the combination of next-generation omics tools for application in several clinical areas, such as oncology, neurology, immunology, and pathology.
Market Report Coverage - Single-Cell Multi-Omics
Market Segmentation
- Product Type – Consumables, Instruments, and Software
- Sample Type – Human Samples, Animal Samples, and Microbial Samples
- Omics Type – Single-Cell Transcriptomics, Single-Cell Genomics, Single-Cell Proteomics
- Application – Clinical Research, Translational Research, and Synthetic Biology
- Technique – Single-Cell Isolation and Dispensing and Single-Cell Analysis
- End User – Academic and Research Institutions, Biopharmaceutical and Biotechnological Companies, Contract Research Organizations, and Other End Users
- North America – U.S., Canada
- Europe – Germany, France, Italy, U.K., Spain, and Rest-of-Europe
- Asia-Pacific – China, Japan, India, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)
- Latin America – Brazil, Mexico, and Rest-of-the-Latin America
- Rest-of-the-World
- Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)
- Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
- Increasing Disposable Income in Emerging Economies
- High Cost of Single-Cell Analysis and Integration of Data
- Limited Availability of Large Online Data Storage and Analysis Platforms
- Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
- Requirement for the Development of Advanced Solutions Based on Single-Cell Technology
- Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
- Expansion into New Research Application such as Single-Cell Metabolomics
1CellBio, Inc., Fluidigm Corporation, 10x Genomics, Inc., NanoString Technologies, Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Mission Bio, Dolomite Bio, Fluxion Biosciences, Berkeley Lights, Inc., RareCyte, Inc., Becton, Dickinson and Company, Takara Bio, Inc., Thermo Fisher Scientific Inc., Namocell, Inc.
Key Questions Answered in this Report:
- What are the major market drivers, challenges, and opportunities in the global single-cell multi-omics market?
- What is the potential impact of biotechnological advancements in the diagnostic industry among end users such as researchers, pathologists, and laboratory technicians?
- What is the current market demand along with future expected demand for the global single-cell multi-omics market?
- What are the key development strategies that are implemented by the major players in order to sustain the competitive market?
- How is each segment of the market expected to grow during the forecast period from 2020 to 2025 based on the following segments:
- product type
- omics type
- technique
- sample type
- application
- end user
- region, namely North America, Europe, Asia-Pacific, Rest-of-the-World (RoW)
- Which are the leading players with significant offerings to the global single-cell multi-omics market? What is the expected market dominance for each of these leading players?
- Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global single-cell multi-omics market?
BIS Research healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others.
The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development. The gradual increase in the prevalence of oncology and rare diseases globally has furthered the single-cell multi-omics market.
Furthermore, several contract research organizations are focusing on the development of single-cell technology-based services, which enable simultaneous analysis of genomics, proteomics, and transcriptomics, providing deeper insights on a disease progression.
Within the research report, the market is segmented on the basis of product type, sample type, omics type, technique, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of high-resolution multiplex diagnostics providing information on cellular interaction and tissue heterogeneity to understand disease biology and pathology. Due to technologically advanced solutions and intense market penetration, 10x Genomics, Inc. has been a pioneer and a significant competitor in this market.
Other key players in the market are NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation.
On the basis of region, North America holds the largest share of the single-cell multi-omics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific is anticipated to grow at the fastest CAGR of 21.53% during the forecast period 2020-2025.
The market utilizes several technologies, such as barcoding, sequencing, mass cytometry, and microscopy, for the development of instruments and assays for single-cell analysis of tissue and cells to gain an understanding of cell heterogeneity and cellular mechanism. Each solution offered by the leading players is the combination of next-generation omics tools for application in several clinical areas, such as oncology, neurology, immunology, and pathology.
EXECUTIVE SUMMARY
1 PRODUCT DEFINITION
1.1 Inclusion and Exclusion
2 SCOPE OF WORK
2.1 12. Scope of the Study
2.2 Key Questions Addressed in the Report
3 RESEARCH METHODOLOGY
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Criteria for Company Profiling
4 MARKET OVERVIEW
4.1 Introduction
4.1.1 Technological Development in Single-Cell Sequencing
4.1.1.1 Advancements in Imaging Techniques for Single-Cell Sequencing
4.1.1.2 Advancements in Single-Cell Collection and Analysis System
5 MARKET DYNAMICS
5.1 Overview
5.2 Impact Analysis
5.3 Market Drivers
5.3.1 Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)
5.3.2 Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
5.3.3 Increasing Disposable Income in Emerging Economies
5.4 Market Restraints
5.4.1 High Cost of Single-Cell Analysis and Integration of Data
5.4.2 Limited Availability of Large Online Data Storage and Analysis Platforms
5.5 Market Opportunities
5.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
5.5.2 Requirement for the Development of Advanced Solutions Based on Single-Cell Technology
5.5.3 Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
5.5.4 Expansion into New Research Applications such as Single-Cell Metabolomics
6 COMPETITIVE INSIGHTS
6.1 Market Share Analysis (by Company), 2019
6.2 Growth Share Analysis (Opportunity Mapping)
6.2.1 By Company
7 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY PRODUCT TYPE)
7.1 Instruments
7.2 Consumables
7.3 Software
8 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY OMICS TYPE)
8.1 Single-Cell Genomics
8.2 Single-Cell Transcriptomics
8.3 Single-Cell Proteomics
9 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY SAMPLE TYPE)
9.1 Human Samples
9.1.1 Cancer Tissues
9.1.2 Stem Cells
9.1.3 Brain Cells
9.1.4 Immune Cells
9.1.5 Other Samples
9.2 Animal Samples
9.3 Microbial Samples
10 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY TECHNIQUE)
10.1 Single-Cell Isolation and Dispensing
10.1.1 Fluorescence-Activated Cell Sorting (FACS)
10.1.2 Manual Cell Picking
10.1.3 Magnetic-Activated Cell Sorting (MACS)
10.1.4 Laser Capture Microdissection
10.1.5 Random Seeding
10.1.6 Microfluidics
10.1.7 Others
10.2 Single-Cell Analysis
10.2.1 Mass Cytometry
10.2.2 Polymerase Chain Reaction
10.2.3 Next-Generation Sequencing
10.2.4 Mass Spectrometry
10.2.5 Others
11 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY APPLICATION)
11.1 Clinical Research
11.1.1 Oncology
11.1.2 Immunology
11.1.3 Neurology
11.1.4 Cell Therapy
11.1.5 Cell Biology
11.1.6 Others
11.2 Translation Research
11.3 Synthetic Biology
12 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY END USER)
12.1 Overview
12.2 Research and Academic Laboratories
12.3 Contract Research Organizations
12.4 Biopharmaceutical and Biotech Companies
12.5 Others End Users
13 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY REGION)
13.1 Overview
13.1.1 U.S.
13.1.2 Canada
13.2 Europe
13.2.1 Germany
13.2.2 France
13.2.3 U.K.
13.2.4 Italy
13.2.5 Spain
13.2.6 Rest-of-Europe
13.3 Asia-Pacific
13.3.1 Japan
13.3.2 Singapore
13.3.3 India
13.3.4 China
13.3.5 Australia
13.3.6 Rest-of-APAC
13.4 Latin America
13.4.1 Mexico
13.4.2 Brazil
13.4.3 Rest-of-Latin America
13.5 Rest-of-the-World
14 COMPANY PROFILES
14.1 Overview
14.2 1CellBio, Inc.
14.2.1 Company Overview
14.2.2 Role of 1CellBio, Inc. in the Global Single-Cell Multi-Omics Market
14.2.3 SWOT Analysis
14.3 Fluidigm Corporation
14.3.1 Company Overview
14.3.2 Role of Fluidigm Corporation in Global Single-Cell Multi-Omics Market
14.3.3 Financials
14.3.4 Key Insights About Financial Health of the Company
14.3.5 SWOT Analysis
14.4 10x Genomics, Inc.
14.4.1 Company Overview
14.4.2 Role of 10x Genomics, Inc. in Global Single-Cell Multi-Omics Market
14.4.3 Financials
14.4.4 Key Insights About Financial Health of the Company
14.4.5 SWOT Analysis
14.5 NanoString Technologies, Inc.
14.5.1 Company Overview
14.5.2 Role of NanoString Technologies, Inc. in Global Single-Cell Multi-Omics Market
14.5.3 Key Insights About Financial Health of the Company
14.5.4 SWOT Analysis
14.6 Bio-Techne Corporation
14.6.1 Company Overview
14.6.2 Role of Bio-Techne Corporation in Global Single-Cell Multi-Omics Market
14.6.3 Key Insights About Financial Health of the Company
14.6.4 SWOT Analysis
14.7 Bio-Rad Laboratories, Inc.
14.7.1 Company Overview
14.7.2 Role of Bio-Rad Laboratories, Inc. in Global Single-Cell Multi-Omics Market
14.7.3 Financials
14.7.4 Key Insights About Financial Health of the Company
14.7.5 SWOT Analysis
14.8 Mission Bio
14.8.1 Company Overview
14.8.2 Role of Mission Bio in the Single-Cell Multi-Omics Market
14.8.3 SWOT Analysis
14.9 Dolomite Bio
14.9.1 Company Overview
14.9.2 Role of Dolomite Bio in the Single-Cell Multi-Omics Market
14.9.3 SWOT Analysis
14.1 Fluxion Biosciences
14.10.1 Company Overview
14.10.2 Role of Fluxion Biosciences in the Global Single-Cell Multi-Omics Market
14.10.3 SWOT Analysis
14.11 Berkeley Lights, Inc.
14.11.1 Company Overview
14.11.2 Role of Berkeley Lights, Inc. in Global Single-Cell Multi-Omics Market
14.11.3 Financials
14.11.4 Key Insights About Financial Health of the Company
14.11.5 SWOT Analysis
14.12 RareCyte, Inc.
14.12.1 Company Overview
14.12.2 Role of RareCyte, Inc. in Global Single-Cell Multi-Omics Market
14.12.3 SWOT Analysis
14.13 Becton, Dickinson and Company
14.13.1 Company Overview
14.13.2 Role of Becton, Dickinson and Company in the Global Single-Cell Multi-Omics Market
14.13.3 Key Insights About Financial Health of the Company
14.13.4 SWOT Analysis
14.14 Takara Bio, Inc.
14.14.1 Company Overview
14.14.2 Role of Takara Bio, Inc. in the Global Single-Cell Multi-Omics Market
14.14.3 Key Insights About Financial Health of Company
14.14.4 SWOT Analysis
14.15 Thermo Fisher Scientific Inc.
14.15.1 Company Overview
14.15.2 Role of Thermo Fisher Scientific Inc. in Global Single-Cell Multi-Omics Market
14.15.3 Financials
14.15.4 Key Insights About Financial Health of the Company
14.15.5 SWOT Analysis
14.16 Namocell, Inc.
14.16.1 Company Overview
14.16.2 Role of Namocell, Inc. in the Single-Cell Multi-Omics Market
14.16.3 SWOT Analysis
15 EMERGING COMPANIES
15.1 Proteona
15.1.1 Company Overview
15.1.2 Role of Proteona in the Single-Cell Multi-Omics Market
15.2 BioTuring, Inc.
15.2.1 Company Overview
15.2.2 Role of BioTuring, Inc. in the Single-Cell Multi-Omics Market
15.3 Scipio Biosciences SAS
15.3.1 Company Overview
15.3.2 Role of Scipio Biosciences SAS in the Single-Cell Multi-Omics Market
15.4 Parse Biosciences, Inc.
15.4.1 Company Overview
15.4.2 Role of Parse Biosciences, Inc. in the Single-Cell Multi-Omics Market
15.5 Shilps Sciences
15.5.1 Company Overview
15.5.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
1 PRODUCT DEFINITION
1.1 Inclusion and Exclusion
2 SCOPE OF WORK
2.1 12. Scope of the Study
2.2 Key Questions Addressed in the Report
3 RESEARCH METHODOLOGY
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Criteria for Company Profiling
4 MARKET OVERVIEW
4.1 Introduction
4.1.1 Technological Development in Single-Cell Sequencing
4.1.1.1 Advancements in Imaging Techniques for Single-Cell Sequencing
4.1.1.2 Advancements in Single-Cell Collection and Analysis System
5 MARKET DYNAMICS
5.1 Overview
5.2 Impact Analysis
5.3 Market Drivers
5.3.1 Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)
5.3.2 Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
5.3.3 Increasing Disposable Income in Emerging Economies
5.4 Market Restraints
5.4.1 High Cost of Single-Cell Analysis and Integration of Data
5.4.2 Limited Availability of Large Online Data Storage and Analysis Platforms
5.5 Market Opportunities
5.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
5.5.2 Requirement for the Development of Advanced Solutions Based on Single-Cell Technology
5.5.3 Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
5.5.4 Expansion into New Research Applications such as Single-Cell Metabolomics
6 COMPETITIVE INSIGHTS
6.1 Market Share Analysis (by Company), 2019
6.2 Growth Share Analysis (Opportunity Mapping)
6.2.1 By Company
7 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY PRODUCT TYPE)
7.1 Instruments
7.2 Consumables
7.3 Software
8 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY OMICS TYPE)
8.1 Single-Cell Genomics
8.2 Single-Cell Transcriptomics
8.3 Single-Cell Proteomics
9 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY SAMPLE TYPE)
9.1 Human Samples
9.1.1 Cancer Tissues
9.1.2 Stem Cells
9.1.3 Brain Cells
9.1.4 Immune Cells
9.1.5 Other Samples
9.2 Animal Samples
9.3 Microbial Samples
10 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY TECHNIQUE)
10.1 Single-Cell Isolation and Dispensing
10.1.1 Fluorescence-Activated Cell Sorting (FACS)
10.1.2 Manual Cell Picking
10.1.3 Magnetic-Activated Cell Sorting (MACS)
10.1.4 Laser Capture Microdissection
10.1.5 Random Seeding
10.1.6 Microfluidics
10.1.7 Others
10.2 Single-Cell Analysis
10.2.1 Mass Cytometry
10.2.2 Polymerase Chain Reaction
10.2.3 Next-Generation Sequencing
10.2.4 Mass Spectrometry
10.2.5 Others
11 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY APPLICATION)
11.1 Clinical Research
11.1.1 Oncology
11.1.2 Immunology
11.1.3 Neurology
11.1.4 Cell Therapy
11.1.5 Cell Biology
11.1.6 Others
11.2 Translation Research
11.3 Synthetic Biology
12 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY END USER)
12.1 Overview
12.2 Research and Academic Laboratories
12.3 Contract Research Organizations
12.4 Biopharmaceutical and Biotech Companies
12.5 Others End Users
13 GLOBAL SINGLE-CELL MULTI-OMICS MARKET (BY REGION)
13.1 Overview
13.1.1 U.S.
13.1.2 Canada
13.2 Europe
13.2.1 Germany
13.2.2 France
13.2.3 U.K.
13.2.4 Italy
13.2.5 Spain
13.2.6 Rest-of-Europe
13.3 Asia-Pacific
13.3.1 Japan
13.3.2 Singapore
13.3.3 India
13.3.4 China
13.3.5 Australia
13.3.6 Rest-of-APAC
13.4 Latin America
13.4.1 Mexico
13.4.2 Brazil
13.4.3 Rest-of-Latin America
13.5 Rest-of-the-World
14 COMPANY PROFILES
14.1 Overview
14.2 1CellBio, Inc.
14.2.1 Company Overview
14.2.2 Role of 1CellBio, Inc. in the Global Single-Cell Multi-Omics Market
14.2.3 SWOT Analysis
14.3 Fluidigm Corporation
14.3.1 Company Overview
14.3.2 Role of Fluidigm Corporation in Global Single-Cell Multi-Omics Market
14.3.3 Financials
14.3.4 Key Insights About Financial Health of the Company
14.3.5 SWOT Analysis
14.4 10x Genomics, Inc.
14.4.1 Company Overview
14.4.2 Role of 10x Genomics, Inc. in Global Single-Cell Multi-Omics Market
14.4.3 Financials
14.4.4 Key Insights About Financial Health of the Company
14.4.5 SWOT Analysis
14.5 NanoString Technologies, Inc.
14.5.1 Company Overview
14.5.2 Role of NanoString Technologies, Inc. in Global Single-Cell Multi-Omics Market
14.5.3 Key Insights About Financial Health of the Company
14.5.4 SWOT Analysis
14.6 Bio-Techne Corporation
14.6.1 Company Overview
14.6.2 Role of Bio-Techne Corporation in Global Single-Cell Multi-Omics Market
14.6.3 Key Insights About Financial Health of the Company
14.6.4 SWOT Analysis
14.7 Bio-Rad Laboratories, Inc.
14.7.1 Company Overview
14.7.2 Role of Bio-Rad Laboratories, Inc. in Global Single-Cell Multi-Omics Market
14.7.3 Financials
14.7.4 Key Insights About Financial Health of the Company
14.7.5 SWOT Analysis
14.8 Mission Bio
14.8.1 Company Overview
14.8.2 Role of Mission Bio in the Single-Cell Multi-Omics Market
14.8.3 SWOT Analysis
14.9 Dolomite Bio
14.9.1 Company Overview
14.9.2 Role of Dolomite Bio in the Single-Cell Multi-Omics Market
14.9.3 SWOT Analysis
14.1 Fluxion Biosciences
14.10.1 Company Overview
14.10.2 Role of Fluxion Biosciences in the Global Single-Cell Multi-Omics Market
14.10.3 SWOT Analysis
14.11 Berkeley Lights, Inc.
14.11.1 Company Overview
14.11.2 Role of Berkeley Lights, Inc. in Global Single-Cell Multi-Omics Market
14.11.3 Financials
14.11.4 Key Insights About Financial Health of the Company
14.11.5 SWOT Analysis
14.12 RareCyte, Inc.
14.12.1 Company Overview
14.12.2 Role of RareCyte, Inc. in Global Single-Cell Multi-Omics Market
14.12.3 SWOT Analysis
14.13 Becton, Dickinson and Company
14.13.1 Company Overview
14.13.2 Role of Becton, Dickinson and Company in the Global Single-Cell Multi-Omics Market
14.13.3 Key Insights About Financial Health of the Company
14.13.4 SWOT Analysis
14.14 Takara Bio, Inc.
14.14.1 Company Overview
14.14.2 Role of Takara Bio, Inc. in the Global Single-Cell Multi-Omics Market
14.14.3 Key Insights About Financial Health of Company
14.14.4 SWOT Analysis
14.15 Thermo Fisher Scientific Inc.
14.15.1 Company Overview
14.15.2 Role of Thermo Fisher Scientific Inc. in Global Single-Cell Multi-Omics Market
14.15.3 Financials
14.15.4 Key Insights About Financial Health of the Company
14.15.5 SWOT Analysis
14.16 Namocell, Inc.
14.16.1 Company Overview
14.16.2 Role of Namocell, Inc. in the Single-Cell Multi-Omics Market
14.16.3 SWOT Analysis
15 EMERGING COMPANIES
15.1 Proteona
15.1.1 Company Overview
15.1.2 Role of Proteona in the Single-Cell Multi-Omics Market
15.2 BioTuring, Inc.
15.2.1 Company Overview
15.2.2 Role of BioTuring, Inc. in the Single-Cell Multi-Omics Market
15.3 Scipio Biosciences SAS
15.3.1 Company Overview
15.3.2 Role of Scipio Biosciences SAS in the Single-Cell Multi-Omics Market
15.4 Parse Biosciences, Inc.
15.4.1 Company Overview
15.4.2 Role of Parse Biosciences, Inc. in the Single-Cell Multi-Omics Market
15.5 Shilps Sciences
15.5.1 Company Overview
15.5.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
LIST OF TABLES
Table 1: Per Sample Clinical Cost of WGS and WES
Table 5.1: Likert Scale
Table 5.2: Impact Analysis of Market Drivers
Table 5.3: Impact Analysis of Market Restraints
Table 5.4: Per Sample Clinical Cost of WGS and WES
Table 7.1: Single-Cell Multi-Omics Market (Instruments)
Table 7.2: Single-Cell Multi-Omics Market (Consumables)
Table 7.3: Single-Cell Multi-Omics Market (Software)
Table 10.1: Products for Fluorescence-Activated Cell Sorting
Table 10.2: Products for Manual Cell Picking
Table 10.3: Products for Magnetic-Activated Cell Sorting
Table 10.4: Products for Laser Microdissection
Table 10.5: Products for Random Seeding/Limited Dilution
Table 10.6: Products for Microfluidics
Table 1: Per Sample Clinical Cost of WGS and WES
Table 5.1: Likert Scale
Table 5.2: Impact Analysis of Market Drivers
Table 5.3: Impact Analysis of Market Restraints
Table 5.4: Per Sample Clinical Cost of WGS and WES
Table 7.1: Single-Cell Multi-Omics Market (Instruments)
Table 7.2: Single-Cell Multi-Omics Market (Consumables)
Table 7.3: Single-Cell Multi-Omics Market (Software)
Table 10.1: Products for Fluorescence-Activated Cell Sorting
Table 10.2: Products for Manual Cell Picking
Table 10.3: Products for Magnetic-Activated Cell Sorting
Table 10.4: Products for Laser Microdissection
Table 10.5: Products for Random Seeding/Limited Dilution
Table 10.6: Products for Microfluidics
LIST OF FIGURES
Figure 1: Impact Analysis of Market Drivers and Market Challenges on Global Single-Cell Multi-Omics Market
Figure 2: Global Single-Cell Multi-Omics Market (by Product Type), $Million, 2020 vs. 2025
Figure 3: Global Single-Cell Multi-Omics Market (by Application), $Million, 2020 vs. 2025
Figure 4: Global Single-Cell Multi-Omics Market (by Omics Type), $Million, 2020 vs. 2025
Figure 5: Global Single-Cell Multi-Omics Market (by Technique), $Million, 2020 vs. 2025
Figure 6: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2020 vs. 2025
Figure 7: Global Single-Cell Multi-Omics Market (by End User), $Million, 2020 vs. 2025
Figure 8: Global Single-Cell Multi-Omics Market Snapshot
Figure 3.1: Primary Research Methodology
Figure 3.2: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.3: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Single-Cell Multi-Omics Approach
Figure 4.2: Evolution of Single-Cell Multi-Omics Technology
Figure 4.4: Three Major Technological Developments in Single-Cell Sequencing
Figure 4.5: Traditional and Modern Approaches for Single-Cell Isolation
Figure 5.1: U.S. Prevalence of Lyme Disease 2009-2018
Figure 5.2: Global Prevalence Rate of Selected Rare Diseases Per 100,000 People
Figure 6.1: Market Share Analysis for the Global Single-Cell Multi-Omics Market, 2019
Figure 6.2: Growth Share Matrix for Global Single-Cell Multi-Omics Market (by Company), 2019
Figure 7.1: Global Single-Cell Multi-Omics Market (by Product Type)
Figure 7.2: Global Single-Cell Multi-Omics Market (Instruments), 2019-2025
Figure 7.3: Global Single-Cell Multi-Omics (Consumables), $Million, 2019-2025
Figure 7.4: Global Single-Cell Multi-Omics Market (Software), $Million, 2019-2025
Figure 8.1: Types of Omics Platforms
Figure 8.2: Global Single-Cell Genomics Market, $Million, 2019-2025
Figure 8.3: Global Single-Cell Transcriptomics Market, $Million, 2019-2025
Figure 8.4: Global Single-Cell Proteomics Market, $Million, 2019-2025
Figure 9.1: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2019-2025
Figure 9.2: Global Single-Cell Multi-Omics Market (Human Samples), $Million, 2019-2025
Figure 9.3: Global Single-Cell Multi-Omics Market (Cancer Tissue), $Million, 2019-2025
Figure 9.4: Global Single-Cell Multi-Omics Market (Stem Cells), $Million, 2019-2025
Figure 9.5: Global Single-Cell Multi-Omics Market (Brain Cells), $Million, 2019-2025
Figure 9.6: Global Single-Cell Multi-Omics Market (Immune Cells), $Million, 2019-2025
Figure 9.7: Global Single-Cell Multi-Omics Market (Other Samples), $Million, 2019-2025
Figure 9.8: Global Single-Cell Multi-Omics Market (Animal Samples), $Million, 2019-2025
Figure 9.9: Global Single-Cell Multi-Omics Market (Microbial Samples), $Million, 2019-2025
Figure 10.1: Global Single-Cell Multi-Omics Market (by Technique)
Figure 10.2: Global Single-Cell Multi-Omics (Single-Cell Isolation and Dispensing), $Million, 2019-2025
Figure 10.3: Global Single-Cell Multi-Omics Market (FACS), $Million, 2019-2025
Figure 10.4: Global Single-Cell Multi-Omics Market (Manual Cell Picking), $Million, 2019-2025
Figure 10.5: Global Single-Cell Multi-Omics Market (MACS), $Million, 2019-2025
Figure 10.6: Global Single-Cell Multi-Omics Market (LCM), $Million, 2019-2025
Figure 10.7: Global Single-Cell Multi-Omics Market (Random Seeding), $Million, 2019-2025
Figure 10.8: Global Single-Cell Multi-Omics Market (Microfluidics), $Million, 2019-2025
Figure 10.9: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 10.10: Global Single-Cell Multi-Omics (Single-Cell Analysis), $Million, 2019-2025
Figure 10.11: Global Single-Cell Multi-Omics Market (Mass Cytometry), $Million, 2019-2025
Figure 10.12: Global Single-Cell Multi-Omics Market (Polymerase Chain Reaction), $Million, 2019-2025
Figure 10.13: Global Single-Cell Multi-Omics Market (Next-Generation Sequencing), $Million, 2019-2025
Figure 10.14: Global Single-Cell Multi-Omics Market (Mass Spectrometry), $Million, 2019-2025
Figure 10.15: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 11.1: Global Single-Cell Multi-Omics Market (Clinical Research), $Million, 2019-2025
Figure 11.2: Global Single-Cell Multi-Omics Market (Oncology), $Million, 2019-2025
Figure 11.3: Global Single-Cell Multi-Omics Market (Immunology), $Million, 2019-2025
Figure 11.4: Global Single-Cell Multi-Omics Market (by Neurology), $Million, 2019-2025
Figure 11.5: Global Single-Cell Multi-Omics Market (Cell Therapy), $Million, 2019-2025
Figure 11.6: Global Single-Cell Multi-Omics Market (Cell Biology), $Million, 2019-2025
Figure 11.7: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 11.8: Global Single-Cell Multi-Omics Market (Translational Research), $Million, 2019-2025
Figure 11.9: Global Single-Cell Multi-Omics Market (Synthetic Biology), $Million, 2019-2025
Figure 12.1: Global Single-Cell Multi-Omics Market (Research and Academia), $Million, 2019-2025
Figure 12.2: Global Single-Cell Multi-Omics Market (Contract Research Organizations), $Million, 2019-2025
Figure 12.3: Global Single-Cell Multi-Omics Market (Biopharmaceutical and Biotech Companies), $Million, 2019-2025
Figure 12.4: Global Single-Cell Multi-Omics Market (Other End Users), $Million, 2019-2025
Figure 13.1: Global Single-Cell Multi-Omics Market (by Region), $Million, 2020 and 2025
Figure 13.2: Global Single-Cell Multi-Omics Market (by Region), $Million, 2019-2025
Figure 13.3: North America Global Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.4: North America: Market Dynamics
Figure 13.5: North America Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.6: U.S. Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.7: Canada Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.8: Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.9: Europe: Market Dynamics
Figure 13.10: Europe Global Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.11: Germany Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.12: France Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.13: U.K. Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.14: Italy Single-Cell Multi-Omics Market, $Millions, 2019-2025
Figure 13.15: Spain Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.16: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.17: Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.18: APAC: Market Dynamics
Figure 13.19: APAC Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.20: Japan Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.21: Singapore Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.22: India Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.23: China Single-Cell Multi-Omics Market, 2019-2025
Figure 13.24: Australia Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.25: RoAPAC Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.26: Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.27: Latin America: Market Dynamics
Figure 13.28: Latin America Single-Cell Multi-Omics Market (by Country), 2019-2025
Figure 13.29: Mexico Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.30: Brazil Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.31: Rest-of-Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.32: RoW Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 14.1: Total Number of Companies Profiled
Figure 14.2: 1CellBio, Inc.: Product Portfolio
Figure 14.3: 1CellBio: SWOT Analysis
Figure 14.4: Fluidigm Corporation: Product Portfolio
Figure 14.5: Fluidigm Corporation: Overall Financials, 2017-2019
Figure 14.6: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 14.7: Fluidigm Corporation.: Revenue (by Region), 2017-2019
Figure 14.8: Fluidigm Corporation: R&D Expenditure, 2017-2019
Figure 14.9: Fluidigm Corporation: SWOT Analysis
Figure 14.10: 10x Genomics, Inc.: Product Portfolio
Figure 14.11: 10x Genomics, Inc.: Overall Financials, 2017-2019
Figure 14.12: 10x Genomics, Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.13: 10x Genomics, Inc.: Revenue (by Region), 2017-2019
Figure 14.14: 10x Genomics, Inc.: R&D Expenditure, 2017-2019
Figure 14.15: 10x Genomics, Inc.: SWOT Analysis
Figure 14.16: NanoString Technologies, Inc.: Product Portfolio
Figure 14.17: NanoString Technologies, Inc.: Overall Financials, 2017-2019
Figure 14.18: NanoString Technologies, Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.19: NanoString Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 14.20: NanoString Technologies, Inc.: R&D Expenditure, 2017-2019
Figure 14.21: NanoString Technologies, Inc.: SWOT Analysis
Figure 14.22: Bio-Techne Corporation: Product Portfolio
Figure 14.23: Bio-Techne Corporation: Overall Financials, 2020-2020
Figure 14.24: Bio-Techne Corporation: Revenue (by Business Segment), 2020-2020
Figure 14.25: Bio-Techne Corporation: Revenue (by Region), 2020-2020
Figure 14.26: Bio-Techne Corporation: R&D Expenditure, 2020-2020
Figure 14.27: Bio-Techne Corporation: SWOT Analysis
Figure 14.28: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 14.29: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 14.30: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 14.31: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 14.32: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 14.33: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 14.34: Mission Bio: Product Portfolio
Figure 14.35: Mission Bio: SWOT Analysis
Figure 14.36: Dolomite Bio: Product Portfolio
Figure 14.37: Dolomite Bio: SWOT Analysis
Figure 14.38: Fluxion Biosciences, Inc.: Product Portfolio
Figure 14.39: Fluxion Biosciences, Inc.: SWOT Analysis
Figure 14.40: Berkeley Lights, Inc.: Product Portfolio
Figure 14.41: Berkeley Lights, Inc.: Overall Financials, 2019-2020
Figure 14.42: Berkeley Lights, Inc.: Revenue (by Segment), 2018-2019
Figure 14.43: Berkeley Lights, Inc.: R&D Expenditure, 2017-2019
Figure 14.44: Berkeley Lights, Inc.: SWOT Analysis
Figure 14.45: RareCyte, Inc.: Overall Product Portfolio
Figure 14.46: RareCyte, Inc.: SWOT Analysis
Figure 14.47: Becton, Dickinson and Company: Product Portfolio
Figure 14.48: Becton, Dickinson and Company: Overall Financials, 2020-2020
Figure 14.49: Becton, Dickinson and Company: Revenue (by Business Segment), 2018-2020
Figure 14.50: Becton, Dickinson and Company: Revenue (by Region), 2018-2020
Figure 14.51: Becton, Dickinson and Company: R&D Expenditure, $Million, 2018-2020
Figure 14.52: Becton, Dickinson and Company: SWOT Analysis
Figure 14.53: Takara Bio, Inc.: Product Portfolio
Figure 14.54: Takara Bio Inc.: Overall Financials, (2018-2020)
Figure 14.55: Takara Bio, Inc.: Revenue (by Business Segment), 2018-2020
Figure 14.56: Takara Bio, Inc.: Revenue (by Region), 2019-2020
Figure 14.57: Takara Bio, Inc., R&D Expenditure, 2018-2020
Figure 14.58: Takara Bio Inc.: SWOT Analysis
Figure 14.59: Thermo Fisher Scientific, Inc.: Product Portfolio
Figure 14.60: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 14.61: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.62: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 14.63: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
Figure 14.64: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 14.65: Namocell, Inc.: Product Portfolio
Figure 14.66: Namocell, Inc.: SWOT Analysis
Figure 15.1: Proteona: Product Portfolio
Figure 15.2: BioTuring, Inc.: Product Portfolio
Figure 15.3: Parse Biosciences, Inc.: Product Portfolio
Figure 15.4: Shilps Sciences: Product Portfolio
Figure 1: Impact Analysis of Market Drivers and Market Challenges on Global Single-Cell Multi-Omics Market
Figure 2: Global Single-Cell Multi-Omics Market (by Product Type), $Million, 2020 vs. 2025
Figure 3: Global Single-Cell Multi-Omics Market (by Application), $Million, 2020 vs. 2025
Figure 4: Global Single-Cell Multi-Omics Market (by Omics Type), $Million, 2020 vs. 2025
Figure 5: Global Single-Cell Multi-Omics Market (by Technique), $Million, 2020 vs. 2025
Figure 6: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2020 vs. 2025
Figure 7: Global Single-Cell Multi-Omics Market (by End User), $Million, 2020 vs. 2025
Figure 8: Global Single-Cell Multi-Omics Market Snapshot
Figure 3.1: Primary Research Methodology
Figure 3.2: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.3: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Single-Cell Multi-Omics Approach
Figure 4.2: Evolution of Single-Cell Multi-Omics Technology
Figure 4.4: Three Major Technological Developments in Single-Cell Sequencing
Figure 4.5: Traditional and Modern Approaches for Single-Cell Isolation
Figure 5.1: U.S. Prevalence of Lyme Disease 2009-2018
Figure 5.2: Global Prevalence Rate of Selected Rare Diseases Per 100,000 People
Figure 6.1: Market Share Analysis for the Global Single-Cell Multi-Omics Market, 2019
Figure 6.2: Growth Share Matrix for Global Single-Cell Multi-Omics Market (by Company), 2019
Figure 7.1: Global Single-Cell Multi-Omics Market (by Product Type)
Figure 7.2: Global Single-Cell Multi-Omics Market (Instruments), 2019-2025
Figure 7.3: Global Single-Cell Multi-Omics (Consumables), $Million, 2019-2025
Figure 7.4: Global Single-Cell Multi-Omics Market (Software), $Million, 2019-2025
Figure 8.1: Types of Omics Platforms
Figure 8.2: Global Single-Cell Genomics Market, $Million, 2019-2025
Figure 8.3: Global Single-Cell Transcriptomics Market, $Million, 2019-2025
Figure 8.4: Global Single-Cell Proteomics Market, $Million, 2019-2025
Figure 9.1: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2019-2025
Figure 9.2: Global Single-Cell Multi-Omics Market (Human Samples), $Million, 2019-2025
Figure 9.3: Global Single-Cell Multi-Omics Market (Cancer Tissue), $Million, 2019-2025
Figure 9.4: Global Single-Cell Multi-Omics Market (Stem Cells), $Million, 2019-2025
Figure 9.5: Global Single-Cell Multi-Omics Market (Brain Cells), $Million, 2019-2025
Figure 9.6: Global Single-Cell Multi-Omics Market (Immune Cells), $Million, 2019-2025
Figure 9.7: Global Single-Cell Multi-Omics Market (Other Samples), $Million, 2019-2025
Figure 9.8: Global Single-Cell Multi-Omics Market (Animal Samples), $Million, 2019-2025
Figure 9.9: Global Single-Cell Multi-Omics Market (Microbial Samples), $Million, 2019-2025
Figure 10.1: Global Single-Cell Multi-Omics Market (by Technique)
Figure 10.2: Global Single-Cell Multi-Omics (Single-Cell Isolation and Dispensing), $Million, 2019-2025
Figure 10.3: Global Single-Cell Multi-Omics Market (FACS), $Million, 2019-2025
Figure 10.4: Global Single-Cell Multi-Omics Market (Manual Cell Picking), $Million, 2019-2025
Figure 10.5: Global Single-Cell Multi-Omics Market (MACS), $Million, 2019-2025
Figure 10.6: Global Single-Cell Multi-Omics Market (LCM), $Million, 2019-2025
Figure 10.7: Global Single-Cell Multi-Omics Market (Random Seeding), $Million, 2019-2025
Figure 10.8: Global Single-Cell Multi-Omics Market (Microfluidics), $Million, 2019-2025
Figure 10.9: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 10.10: Global Single-Cell Multi-Omics (Single-Cell Analysis), $Million, 2019-2025
Figure 10.11: Global Single-Cell Multi-Omics Market (Mass Cytometry), $Million, 2019-2025
Figure 10.12: Global Single-Cell Multi-Omics Market (Polymerase Chain Reaction), $Million, 2019-2025
Figure 10.13: Global Single-Cell Multi-Omics Market (Next-Generation Sequencing), $Million, 2019-2025
Figure 10.14: Global Single-Cell Multi-Omics Market (Mass Spectrometry), $Million, 2019-2025
Figure 10.15: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 11.1: Global Single-Cell Multi-Omics Market (Clinical Research), $Million, 2019-2025
Figure 11.2: Global Single-Cell Multi-Omics Market (Oncology), $Million, 2019-2025
Figure 11.3: Global Single-Cell Multi-Omics Market (Immunology), $Million, 2019-2025
Figure 11.4: Global Single-Cell Multi-Omics Market (by Neurology), $Million, 2019-2025
Figure 11.5: Global Single-Cell Multi-Omics Market (Cell Therapy), $Million, 2019-2025
Figure 11.6: Global Single-Cell Multi-Omics Market (Cell Biology), $Million, 2019-2025
Figure 11.7: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 11.8: Global Single-Cell Multi-Omics Market (Translational Research), $Million, 2019-2025
Figure 11.9: Global Single-Cell Multi-Omics Market (Synthetic Biology), $Million, 2019-2025
Figure 12.1: Global Single-Cell Multi-Omics Market (Research and Academia), $Million, 2019-2025
Figure 12.2: Global Single-Cell Multi-Omics Market (Contract Research Organizations), $Million, 2019-2025
Figure 12.3: Global Single-Cell Multi-Omics Market (Biopharmaceutical and Biotech Companies), $Million, 2019-2025
Figure 12.4: Global Single-Cell Multi-Omics Market (Other End Users), $Million, 2019-2025
Figure 13.1: Global Single-Cell Multi-Omics Market (by Region), $Million, 2020 and 2025
Figure 13.2: Global Single-Cell Multi-Omics Market (by Region), $Million, 2019-2025
Figure 13.3: North America Global Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.4: North America: Market Dynamics
Figure 13.5: North America Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.6: U.S. Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.7: Canada Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.8: Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.9: Europe: Market Dynamics
Figure 13.10: Europe Global Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.11: Germany Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.12: France Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.13: U.K. Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.14: Italy Single-Cell Multi-Omics Market, $Millions, 2019-2025
Figure 13.15: Spain Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.16: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.17: Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.18: APAC: Market Dynamics
Figure 13.19: APAC Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.20: Japan Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.21: Singapore Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.22: India Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.23: China Single-Cell Multi-Omics Market, 2019-2025
Figure 13.24: Australia Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.25: RoAPAC Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.26: Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.27: Latin America: Market Dynamics
Figure 13.28: Latin America Single-Cell Multi-Omics Market (by Country), 2019-2025
Figure 13.29: Mexico Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.30: Brazil Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.31: Rest-of-Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.32: RoW Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 14.1: Total Number of Companies Profiled
Figure 14.2: 1CellBio, Inc.: Product Portfolio
Figure 14.3: 1CellBio: SWOT Analysis
Figure 14.4: Fluidigm Corporation: Product Portfolio
Figure 14.5: Fluidigm Corporation: Overall Financials, 2017-2019
Figure 14.6: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 14.7: Fluidigm Corporation.: Revenue (by Region), 2017-2019
Figure 14.8: Fluidigm Corporation: R&D Expenditure, 2017-2019
Figure 14.9: Fluidigm Corporation: SWOT Analysis
Figure 14.10: 10x Genomics, Inc.: Product Portfolio
Figure 14.11: 10x Genomics, Inc.: Overall Financials, 2017-2019
Figure 14.12: 10x Genomics, Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.13: 10x Genomics, Inc.: Revenue (by Region), 2017-2019
Figure 14.14: 10x Genomics, Inc.: R&D Expenditure, 2017-2019
Figure 14.15: 10x Genomics, Inc.: SWOT Analysis
Figure 14.16: NanoString Technologies, Inc.: Product Portfolio
Figure 14.17: NanoString Technologies, Inc.: Overall Financials, 2017-2019
Figure 14.18: NanoString Technologies, Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.19: NanoString Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 14.20: NanoString Technologies, Inc.: R&D Expenditure, 2017-2019
Figure 14.21: NanoString Technologies, Inc.: SWOT Analysis
Figure 14.22: Bio-Techne Corporation: Product Portfolio
Figure 14.23: Bio-Techne Corporation: Overall Financials, 2020-2020
Figure 14.24: Bio-Techne Corporation: Revenue (by Business Segment), 2020-2020
Figure 14.25: Bio-Techne Corporation: Revenue (by Region), 2020-2020
Figure 14.26: Bio-Techne Corporation: R&D Expenditure, 2020-2020
Figure 14.27: Bio-Techne Corporation: SWOT Analysis
Figure 14.28: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 14.29: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 14.30: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 14.31: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 14.32: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 14.33: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 14.34: Mission Bio: Product Portfolio
Figure 14.35: Mission Bio: SWOT Analysis
Figure 14.36: Dolomite Bio: Product Portfolio
Figure 14.37: Dolomite Bio: SWOT Analysis
Figure 14.38: Fluxion Biosciences, Inc.: Product Portfolio
Figure 14.39: Fluxion Biosciences, Inc.: SWOT Analysis
Figure 14.40: Berkeley Lights, Inc.: Product Portfolio
Figure 14.41: Berkeley Lights, Inc.: Overall Financials, 2019-2020
Figure 14.42: Berkeley Lights, Inc.: Revenue (by Segment), 2018-2019
Figure 14.43: Berkeley Lights, Inc.: R&D Expenditure, 2017-2019
Figure 14.44: Berkeley Lights, Inc.: SWOT Analysis
Figure 14.45: RareCyte, Inc.: Overall Product Portfolio
Figure 14.46: RareCyte, Inc.: SWOT Analysis
Figure 14.47: Becton, Dickinson and Company: Product Portfolio
Figure 14.48: Becton, Dickinson and Company: Overall Financials, 2020-2020
Figure 14.49: Becton, Dickinson and Company: Revenue (by Business Segment), 2018-2020
Figure 14.50: Becton, Dickinson and Company: Revenue (by Region), 2018-2020
Figure 14.51: Becton, Dickinson and Company: R&D Expenditure, $Million, 2018-2020
Figure 14.52: Becton, Dickinson and Company: SWOT Analysis
Figure 14.53: Takara Bio, Inc.: Product Portfolio
Figure 14.54: Takara Bio Inc.: Overall Financials, (2018-2020)
Figure 14.55: Takara Bio, Inc.: Revenue (by Business Segment), 2018-2020
Figure 14.56: Takara Bio, Inc.: Revenue (by Region), 2019-2020
Figure 14.57: Takara Bio, Inc., R&D Expenditure, 2018-2020
Figure 14.58: Takara Bio Inc.: SWOT Analysis
Figure 14.59: Thermo Fisher Scientific, Inc.: Product Portfolio
Figure 14.60: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 14.61: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.62: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 14.63: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
Figure 14.64: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 14.65: Namocell, Inc.: Product Portfolio
Figure 14.66: Namocell, Inc.: SWOT Analysis
Figure 15.1: Proteona: Product Portfolio
Figure 15.2: BioTuring, Inc.: Product Portfolio
Figure 15.3: Parse Biosciences, Inc.: Product Portfolio
Figure 15.4: Shilps Sciences: Product Portfolio
